Related references
Note: Only part of the references are listed.Imaging features of diffuse hemispheric glioma, H3 G34-mutant: Report of 4 cases
Tuba Kalelioglu et al.
JOURNAL OF NEURORADIOLOGY (2023)
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments
Vincenzo Di Nunno et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2023)
Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive neurodegeneration
Sima Khazaei et al.
CELL (2023)
Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021
Sandra Pohl et al.
CLINICAL NEUROPATHOLOGY (2023)
A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
Michael McNicholas et al.
CANCER DISCOVERY (2023)
Integrated genetic profiling of archival pediatric high-grade glial tumors and reassessment with 2021 WHO classification of paediatric CNS tumours
Linda D. Cooley et al.
CANCER GENETICS (2023)
H3G34-mutant diffuse hemispheric glioma with osseous metastases: a case report and literature review
Nina Yu et al.
CNS oncology (2023)
Tumor microenvironment in glioblastoma: Current and emerging concepts
Pratibha Sharma et al.
NEURO-ONCOLOGY ADVANCES (2023)
H3 G34-mutant high-grade gliomas: integrated clinical, imaging and pathological characterisation of a single-centre case series
Jose Pedro Lavrador et al.
ACTA NEUROCHIRURGICA (2023)
Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of Hoxa cluster genes and promotion of neuronal lineage
Aalaa S. Abdallah et al.
NEURO-ONCOLOGY ADVANCES (2023)
The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas
Huy Gia Vuong et al.
CANCER (2022)
Neuroimaging features of diffuse hemispheric glioma, H3 G34-mutant: A case series and systematic review
Ryo Kurokawa et al.
JOURNAL OF NEUROIMAGING (2022)
High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?
Wanming Hu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2022)
Germline MUTYH mutations and high-grade gliomas: Novel evidence for a potential association
Gabor Bedics et al.
GENES CHROMOSOMES & CANCER (2022)
Molecular alterations in the integrated diagnosis of pediatric glial and glioneuronal tumors: A single center experience
Sandra Lorena Colli et al.
PLOS ONE (2022)
A Saccharomyces cerevisiae model and screen to define the functional consequences of oncogenic histone missense mutations
Laramie D. Lemon et al.
G3-GENES GENOMES GENETICS (2022)
The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles' Heel
Paul Huchede et al.
BIOMEDICINES (2022)
CTNI-31. COG ACNS1721: PHASE 2 STUDY OF VELIPARIB AND LOCAL IRRADIATION, FOLLOWED BY MAINTENANCE VELIPARIB AND TEMOZOLOMIDE, IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA WITHOUT H3 K27M OR BRAF MUTATIONS
Matthias Karajannis et al.
NEURO-ONCOLOGY (2022)
Oncohistone interactome profiling uncovers contrasting oncogenic mechanisms and identifies potential therapeutic targets in high grade glioma
Robert Siddaway et al.
ACTA NEUROPATHOLOGICA (2022)
Pediatric glioblastoma cells are sensitive to drugs that inhibit eIF2α dephosphorylation and its phosphomimetic S51D variant
Karin Eytan et al.
FRONTIERS IN ONCOLOGY (2022)
Extent of Tumor Resection and Survival in Pediatric Patients With High-Grade Gliomas A Systematic Review and Meta-analysis
Rami Hatoum et al.
JAMA NETWORK OPEN (2022)
Utility of arterial spin labeling for objective assessment of intratumoral microvessels in diffuse hemispheric glioma, H3 G34R-mutant: A case report and literature review
Kei Kitakami et al.
Radiology Case Reports (2022)
Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification
Francesca Gianno et al.
PATHOLOGICA (2022)
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
Santiago Haase et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
The dominant TP53 hotspot mutation in IDH-mutant astrocytoma, R273C, has distinctive pathologic features and sex-specific prognostic implications
Daniel F. Marker et al.
NEURO-ONCOLOGY ADVANCES (2022)
Systematic review of diffuse hemispheric glioma, H3 G34-mutant: Outcomes and associated clinical factors
Cameron Crowell et al.
NEURO-ONCOLOGY ADVANCES (2022)
EvaluatingH3F3AK27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies
Vinicius Fernandes Oliveira et al.
CHILDS NERVOUS SYSTEM (2021)
Morphological diversity in H3G34-mutant high-grade gliomas: Ganglionic and epithelioid features
Ahmed Gilani et al.
CLINICAL NEUROPATHOLOGY (2021)
H3 G34-mutant high-grade glioma
Ka Young Lim et al.
BRAIN TUMOR PATHOLOGY (2021)
Correlation Between Immunohistochemistry and Sequencing in H3G34-Mutant Gliomas
Francesca Gianno et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center
Aruna Nambirajan et al.
CHILDS NERVOUS SYSTEM (2021)
Post-treatment hypermutation in a recurrent diffuse glioma with H3.3 p.G34 Mutation
Matthew D. Wood et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)
Regional identity of human neural stem cells determines oncogenic responses to histone H3.3 mutants
Raul Bardini Bressan et al.
CELL STEM CELL (2021)
Dissecting the impact of regional identity and the oncogenic role of human-specific NOTCH2NL in an hESC model of H3.3G34R-mutant glioma
Kosuke Funato et al.
CELL STEM CELL (2021)
Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas
Stefan R. Sweha et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Suprising phenotypic diversity of cancer-associated mutations of Gly 34 in the histone H3 tail
Brandon R. Lowe et al.
ELIFE (2021)
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
H3K36 trimethylation-mediated biological functions in cancer
Chu Xiao et al.
CLINICAL EPIGENETICS (2021)
Advanced Magnetic Resonance Imaging in Pediatric Glioblastomas
Fabricio Guimaraes Goncalves et al.
FRONTIERS IN NEUROLOGY (2021)
Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas
M. Udugama et al.
NATURE COMMUNICATIONS (2021)
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Ruchi Kumari et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome
Melanie Schoof et al.
ACTA NEUROPATHOLOGICA (2021)
Histone H3.3 G34-mutant Diffuse Gliomas in Adults
Leiming Wang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
KS01.3.A Tumoral MHC class II expression in gliomas drives T cell exhaustion
Y Chih et al.
NEURO-ONCOLOGY (2021)
Diffuse hemispheric glioma, H3 G34-mutant: Genomic landscape of a new tumor entity and prospects for targeted therapy
Calixto-Hope G. Lucas et al.
NEURO-ONCOLOGY (2021)
Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma
Simone Minasi et al.
CHILDS NERVOUS SYSTEM (2021)
Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial
Daniel Rodriguez Gutierrez et al.
CLINICAL CANCER RESEARCH (2020)
Extracranial Metastases From Glioblastoma With Primitive Neuronal Components on FDG PET/CT
Matthew D. Kay et al.
CLINICAL NUCLEAR MEDICINE (2020)
High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts
Alexandre Roux et al.
NEURO-ONCOLOGY (2020)
RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma
Fangfang Jiao et al.
SCIENCE ADVANCES (2020)
Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children's Hospital experience
Erin E. Crotty et al.
JOURNAL OF NEURO-ONCOLOGY (2020)
Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings
Meaghan Morris et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression
Siddhant U. Jain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Histone H3.3G34-Mutant Intemeuron Progenitors Co-opt PDGFRA for Gliomagenesis
Carol C. L. Chen et al.
CELL (2020)
PRC2 and EHMT1 regulate H3K27me2 and H3K27me3 establishment across the zygote genome
Tie-Gang Meng et al.
NATURE COMMUNICATIONS (2020)
Effects of H3.3G34V mutation on genomic H3K36 and H3K27 methylation patterns in isogenic pediatric glioma cells
Tina Yi-Ting Huang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?
Michael Weller et al.
CURRENT OPINION IN NEUROLOGY (2020)
Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone
Pavlo Lutsik et al.
NATURE COMMUNICATIONS (2020)
Radiological and Immunostaining Characteristics of H3.3 G34R-Mutant Glioma: A Report of 3 Cases and Review of the Literature
Shumpei Onishi et al.
PEDIATRIC NEUROSURGERY (2020)
Cerebral hemispheric glioblastoma with PNET-like morphology and histone H3.3 G34 mutation in younger patients: Report of three rare cases and diagnostic pitfalls
Yuanyuan Cheng et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2020)
Applications of molecular neuro-oncology - a review of diffuse glioma integrated diagnosis and emerging molecular entities
Matthew D. Wood et al.
DIAGNOSTIC PATHOLOGY (2019)
H3F3A-G34R mutant high grade neuroepithelial neoplasms with glial and dysplastic ganglion cell components
Felipe Andreiuolo et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Histone H3 Mutations: An Updated View of Their Role in Chromatin Deregulation and Cancer
Brandon R. Lowe et al.
CANCERS (2019)
Extraneural Metastases From a High-Grade Glioma (HGG) With an H3F3A G34R Mutation
Amit Jethanandani et al.
FRONTIERS IN ONCOLOGY (2019)
Anaplastic pleomorphic xanthoastrocytoma associated with an H3G34 mutation: a case report with review of literature
Shoh Sasaki et al.
BRAIN TUMOR PATHOLOGY (2019)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2019)
Direct Targeting of MYCN Gene Amplification by Site-Specific DNA Alkylation in Neuroblastoma
Hiroyuki Yoda et al.
CANCER RESEARCH (2019)
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Yuan Cheng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Low FoxG1 and high Olig-2 labelling indices define a prognostically favourable subset in isocitrate dehydrogenase (IDH)-mutant gliomas
S. Schaefer et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial
Alan Mackay et al.
CANCER CELL (2018)
Rpp29 regulates histone H3.3 chromatin assembly through transcriptional mechanisms
Prashanth Krishna Shastrula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma
Jacques Grill et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Historadiological correlations in high-grade glioma with the histone 3.3 G34R mutation
Julien Puntonet et al.
JOURNAL OF NEURORADIOLOGY (2018)
Molecular classification of adult gliomas: recent advances and future perspectives
Marc Barritault et al.
CURRENT OPINION IN ONCOLOGY (2018)
Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3-MutS alpha interaction
Jun Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma
Hsiao P. J. Voon et al.
NATURE COMMUNICATIONS (2018)
Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET
Franziska J. Vettermann et al.
CLINICAL NUCLEAR MEDICINE (2018)
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial
Eugene I. Hwang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3
Jinyeong Lim et al.
SCIENTIFIC DATA (2018)
Histone modifications and their role in epigenetics of atopy and allergic diseases
Bilal Alaskhar Alhamwe et al.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY (2018)
Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population
Saoussen Trabelsi et al.
MOLECULAR NEUROBIOLOGY (2017)
Molecular basis for the role of oncogenic histone mutations in modulating H3K36 methylation
Yinglu Zhang et al.
SCIENTIFIC REPORTS (2017)
Histone H3G34R mutation causes replication stress, homologous recombination defects and genomic instability in S. pombe
Rajesh K. Yadav et al.
ELIFE (2017)
Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours
Farhana Haque et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
Tina Y. Huang et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas
Ralph Salloum et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution
Koji Yoshimoto et al.
BRAIN TUMOR PATHOLOGY (2017)
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2016)
Gliomatosis cerebri: no evidence for a separate brain tumor entity
Ulrich Herrlinger et al.
ACTA NEUROPATHOLOGICA (2016)
A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas
Trent R. Hummel et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Biomarker-based prognostic stratification of young adult glioblastoma
Rui-qi Zhang et al.
ONCOTARGET (2016)
Gliomatosis cerebri in children shares molecular characteristics with other pediatric gliomas
Alberto Broniscer et al.
ACTA NEUROPATHOLOGICA (2016)
Molecular basis for oncohistone 113 recognition by SETD2 methyltransferase
Shuang Yang et al.
GENES & DEVELOPMENT (2016)
Distinct Histomorphology in Molecular Subgroups of Glioblastomas in Young Patients
Julia E. Neumann et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2016)
Recurrent MET fusion genes represent a drug target in pediatric glioblastoma
Sebastian Bender et al.
NATURE MEDICINE (2016)
ATRX immunostaining predicts IDH and H3F3A status in gliomas
Azadeh Ebrahimi et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
H3K36ac Is an Evolutionary Conserved Plant Histone Modification That Marks Active Genes
Walid Mahrez et al.
PLANT PHYSIOLOGY (2016)
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
Andrey Korshunov et al.
ACTA NEUROPATHOLOGICA (2015)
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2015)
Altered global histone-trimethylation code and H3F3A-ATRX mutation in pediatric GBM
Pankaj Pathak et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Molecular analysis of diffuse intrinsic brainstem gliomas in adults
German Reyes-Botero et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Gang Wu et al.
NATURE GENETICS (2014)
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Adam M. Fontebasso et al.
NATURE GENETICS (2014)
The prognostic role of intragenic copy number breakpoints and identification of novel fusion genes in paediatric high grade glioma
Diana Carvalho et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
Adam M. Fontebasso et al.
ACTA NEUROPATHOLOGICA (2013)
Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas
Barbara S. Paugh et al.
CANCER RESEARCH (2013)
A lesson learned from the H3.3K27M mutation found in pediatric glioma A new approach to the study of the function of histone modifications in vivo?
Kui Ming Chan et al.
CELL CYCLE (2013)
H3.3 G34R mutations in pediatric primitive neuroectodermal tumors of central nervous system (CNS-PNET) and pediatric glioblastomas: possible diagnostic and therapeutic implications?
Marco Gessi et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Peter W. Lewis et al.
SCIENCE (2013)
Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
Lynn Bjerke et al.
CANCER DISCOVERY (2013)
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Dominik Sturm et al.
CANCER CELL (2012)
Epigenetic modifications in cancer
R. Kanwal et al.
CLINICAL GENETICS (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas
Stephanie Puget et al.
PLOS ONE (2012)
Structures of human nucleosomes containing major histone H3 variants
Hiroaki Tachiwana et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2011)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
The Role of the Leukemia Inhibitory Factor (LIF) - Pathway in Derivation and Maintenance of Murine Pluripotent Stem Cells
Urs Graf et al.
GENES (2011)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes
Heather C. Mefford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification
Stephanie A. Morris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain
D Zagzag et al.
LABORATORY INVESTIGATION (2005)
Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA)
Y Takamura et al.
GLIA (2004)
The caudal ganglionic eminence is a source of distinct cortical and subcortical cell populations
S Nery et al.
NATURE NEUROSCIENCE (2002)